Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

37.59
Delayed Data
As of Nov 17
 +0.09 / +0.24%
Today’s Change
29.39
Today|||52-Week Range
45.87
-1.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$20.2B

Company Description

Mylan N.V., is a pharmaceutical company which engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. The company was founded on July 7, 2014 and is headquartered in Hatfield, United Kingdom.

Contact Information

Mylan NV
Building 4
Hatfield Hertfordshire EN6 1AG
P:441707853000
Investor Relations:

Employees

Shareholders

Individual stakeholders5.52%
Mutual fund holders40.53%
Other institutional37.06%

Top Executives

Heather M. BreschChief Executive Officer & Director
Rajiv MalikPresident & Director
Kenneth Scott ParksChief Financial Officer
Jonathan R. CollinsVice President & Head-eCommerce
Adele M. GulfoChief Strategy Officer